Suppr超能文献

肩袖病变中肩峰下注射的疗效:系统评价和荟萃分析方案。

Effectiveness of subacromial injections in rotator cuff lesions: systematic review and meta-analysis protocol.

机构信息

Orthopaedics and Traumatology - Division of Hand Surgery and Upper Limb, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil

Orthopaedics and Traumatology - Division of Hand Surgery and Upper Limb, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil.

出版信息

BMJ Open. 2022 Nov 2;12(11):e062114. doi: 10.1136/bmjopen-2022-062114.

Abstract

INTRODUCTION

Subacromial injections are therapeutic options for rotator cuff injuries, with consistent results not well established yet for each drug applied. The objective of this systematic review and meta-analysis is to analyse the effectiveness of the substances used in subacromial injections for the treatment of rotator cuff injuries and shoulder impingement syndrome, considering the functional gain and pain improvement of the shoulder.

METHODS AND ANALYSIS

Beginning in November 2022, we will perform a detailed search using the MEDLINE/PubMed, EMBASE, Cochrane Central Register of Controlled Trials and LILACS databases. Relevant grey literature (reference lists, conference abstracts and academic papers) will also be included.Two reviewers will independently screen and extract the information from the literature. Bias and quality of the included studies will be evaluated using the risk of bias assessment tool provided by the Cochrane Collaboration. Statistical analyses will be performed using Review Manager V.5.4 software.

ETHICS AND DISSEMINATION

Approval and patient informed consent are not required because we will only include published literature. The results of this research will be disseminated in a peer-reviewed journal and likely through other scientific events.

PROSPERO REGISTRATION NUMBER

CRD42020199292.

摘要

简介

肩峰下注射是治疗肩袖损伤的一种治疗选择,但每种应用药物的效果尚未得到明确证实。本系统评价和荟萃分析的目的是分析肩峰下注射治疗肩袖损伤和肩峰下撞击综合征的物质的有效性,同时考虑到肩部功能的改善和疼痛的减轻。

方法和分析

从 2022 年 11 月开始,我们将使用 MEDLINE/PubMed、EMBASE、Cochrane 中央对照试验注册库和 LILACS 数据库进行详细搜索。还将包括相关的灰色文献(参考文献、会议摘要和学术论文)。两名评审员将独立筛选和提取文献中的信息。将使用 Cochrane 协作提供的偏倚风险评估工具评估纳入研究的偏倚和质量。统计分析将使用 Review Manager V.5.4 软件进行。

伦理和传播

由于我们只包括已发表的文献,因此不需要批准和患者知情同意。本研究的结果将在同行评议的期刊上发表,并可能通过其他科学活动进行传播。

PROSPERO 注册号:CRD42020199292。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0b/9639075/ae16f71b5514/bmjopen-2022-062114f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验